PhotoGolden State Medical Supply (GSMS) is recalling all quantities and lots of Ranitidine HCl 150-mg and 300-mg capsules.

The product may contain N-Nitrosodimethylamine (NDMA ), a substance that could cause cancer, above levels established by the FDA.

The firm has not received any reports of adverse events.

The following products, used for treatment of gastric disorders, are being recalled:

Product DescriptionGSMS NDCGSMS Lot #Expiration Date
RANITIDINE HCl 150MG CAPSULES 500 Ct Bottle51407-097-05GS02397010/31/2020
GS02610810/31/2020
GS02609910/31/2020
GS02683810/31/2020
GS02570210/31/2020
GS02727210/31/2020
GS02727305/31/2021
RANITIDINE HCl 300MG CAPSULES 100 Ct Bottle51407-098-01GS02397110/31/2020
GS02552710/31/2020
GS02552610/31/2020
GS02611410/31/2020
GS02581310/31/2020
GS02618910/31/2020
GS02755507/31/2021
GS02619005/31/2021
GS02622005/31/2021
GS02658405/31/2021
GS02713905/31/2021
GS02755405/31/2021

The lots being recalled were primarily sold to AmerisourceBergen, McKesson, and Tricare Mail Order Pharmacies (TMOP).

What to do

Patients taking the recalled products should consult with their physician, pharmacist, or healthcare provider about an alternative treatment prior to discontinuing the use of the medication.

Once an alternative treatment has been prescribed, patients should contact the recall processor at (866) 382-8606 or by email at Novitiumpharma6639@stericycle.com to obtain instructions and kit for returning the remaining product.

Consumers with questions may contact GSMS at (800) 284-8633, ext. 215 Monday through Friday from 7:30 AM to 4:00 PM (PT) by fax at (805) 437-7588 or by email at recalls@gsms.us

Are your appliances protected?

Take our 2-minute quiz to find the right home warranty company for you.


    Share your Comments